Wei Jin

2.4k total citations
72 papers, 1.7k citations indexed

About

Wei Jin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wei Jin has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 33 papers in Oncology and 27 papers in Cancer Research. Recurrent topics in Wei Jin's work include Cancer Cells and Metastasis (9 papers), Cancer-related molecular mechanisms research (9 papers) and Breast Cancer Treatment Studies (7 papers). Wei Jin is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer-related molecular mechanisms research (9 papers) and Breast Cancer Treatment Studies (7 papers). Wei Jin collaborates with scholars based in China, United States and Switzerland. Wei Jin's co-authors include Hefen Sun, Liangdong Li, Jiong Wu, Shuiping Gao, Yang Zhao, Wenyan Fu, Zhi‐Ming Shao, Xianjun Yu, Hua-Xiang Xu and Jin-Zhi Xu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Wei Jin

68 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Jin China 23 1.0k 577 523 262 182 72 1.7k
Yi Bao China 22 1.2k 1.1× 385 0.7× 787 1.5× 304 1.2× 173 1.0× 44 1.7k
Limei Liu China 22 1.1k 1.1× 565 1.0× 507 1.0× 125 0.5× 182 1.0× 42 1.7k
Johann Zimmermann Switzerland 23 1.2k 1.2× 764 1.3× 427 0.8× 205 0.8× 140 0.8× 41 1.9k
Shalom Madar Israel 22 1.0k 1.0× 736 1.3× 583 1.1× 202 0.8× 163 0.9× 27 1.6k
Sheng-Chieh Hsu Taiwan 16 1.0k 1.0× 811 1.4× 364 0.7× 286 1.1× 151 0.8× 16 1.7k
Oona Delpuech United Kingdom 20 1.1k 1.0× 433 0.8× 460 0.9× 243 0.9× 141 0.8× 33 1.7k
Jun Song China 23 990 1.0× 449 0.8× 675 1.3× 152 0.6× 175 1.0× 69 1.6k
Xiaoyan Xu China 23 1.3k 1.3× 433 0.8× 487 0.9× 198 0.8× 225 1.2× 79 1.8k
Susan E. Bray United Kingdom 20 1.1k 1.1× 711 1.2× 405 0.8× 162 0.6× 142 0.8× 40 1.7k
Haluk Yuzugullu France 10 1.4k 1.3× 541 0.9× 305 0.6× 307 1.2× 154 0.8× 12 1.8k

Countries citing papers authored by Wei Jin

Since Specialization
Citations

This map shows the geographic impact of Wei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Jin more than expected).

Fields of papers citing papers by Wei Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Jin. The network helps show where Wei Jin may publish in the future.

Co-authorship network of co-authors of Wei Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Jin. A scholar is included among the top collaborators of Wei Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Jin. Wei Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yuanyuan, et al.. (2024). Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer. Frontiers in Cell and Developmental Biology. 12. 1448037–1448037. 2 indexed citations
2.
Sun, Hefen, et al.. (2024). IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene. 43(10). 693–702. 5 indexed citations
3.
Sun, Hefen, et al.. (2022). HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐β Canonical and Noncanonical Pathways. Advanced Science. 9(12). e2105672–e2105672. 16 indexed citations
4.
Zhao, Yang, et al.. (2022). NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb/TβR1/EMT axis. Oncogene. 41(25). 3409–3422. 7 indexed citations
5.
Sun, Hefen, Liangdong Li, I Weng Lao, et al.. (2022). Single‐cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases. Clinical and Translational Medicine. 12(11). e1101–e1101. 38 indexed citations
6.
Zhao, Yuanyuan, et al.. (2022). DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2. Cell Death and Disease. 13(2). 105–105. 13 indexed citations
7.
Chen, Mengting, Yang Zhao, Xueli Yang, et al.. (2021). NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis. Breast Cancer Research and Treatment. 187(2). 349–362. 29 indexed citations
8.
Li, Liangdong, Yang Bai, Deheng Li, et al.. (2021). Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. Disease Markers. 2021. 1–18. 8 indexed citations
9.
Sun, Hefen, Mengting Chen, Yang Liu, et al.. (2019). Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes. Cancer Medicine. 8(6). 2840–2857. 8 indexed citations
10.
Wang, Dezhong, Xinyu Zhao, Tianyang Zhao, et al.. (2019). FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation. Cell Death and Disease. 10(6). 464–464. 74 indexed citations
11.
Chi, Yayun, Jingyan Xue, Sheng Huang, et al.. (2019). CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Theranostics. 9(23). 6840–6855. 42 indexed citations
12.
Zhang, Shirong, Lie Yao, Wenquan Wang, et al.. (2018). Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 25(13). 3984–3993. 23 indexed citations
13.
Fu, Wenyan, Hefen Sun, Yang Zhao, et al.. (2018). Targeted delivery of CD44s-siRNA by ScFv overcomes de novo resistance to cetuximab in triple negative breast cancer. Molecular Immunology. 99. 124–133. 14 indexed citations
14.
15.
Gao, Shuiping, Hefen Sun, Honglin Jiang, et al.. (2015). Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer. Tumor Biology. 37(1). 1279–1287. 20 indexed citations
16.
Jin, Wei. (2011). Effects of berberine on insulin resistance and serum adiponectin of nonalcoholic fatty liver patients. 6 indexed citations
17.
Jin, Wei, Yang Liu, Li Chen, et al.. (2010). Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Research and Treatment. 125(3). 699–713. 16 indexed citations
18.
Cao, A‐Yong, Ke‐Da Yu, Wenjin Yin, et al.. (2009). Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population. Breast Cancer Research and Treatment. 123(1). 133–138. 10 indexed citations
19.
Jin, Wei, et al.. (2009). UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. Breast Cancer Research and Treatment. 124(1). 39–48. 34 indexed citations
20.
Jin, Wei & Gary M. Green. (2003). Circulating Ethanol Does Not Stimulate Pancreatic Secretion in Conscious Rats. Pancreas. 27(4). e90–e95. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi Bao Breakdown of academic impact, for papers by Limei Liu Breakdown of academic impact, for papers by Johann Zimmermann Breakdown of academic impact, for papers by Shalom Madar Breakdown of academic impact, for papers by Sheng-Chieh Hsu Breakdown of academic impact, for papers by Oona Delpuech Breakdown of academic impact, for papers by Jun Song Breakdown of academic impact, for papers by Xiaoyan Xu Breakdown of academic impact, for papers by Susan E. Bray Breakdown of academic impact, for papers by Haluk Yuzugullu
Rankless by CCL
2026